Efficacy comparison of multipoint and single point scanning panretinal laser photocoagulation in non-proliferative diabetic retinopathy treatment [0.03%]
弥漫性视网膜激光光凝治疗非增殖型糖尿病视网膜病变的疗效分析
Yang-Zhou Zhang,Hua Gong,Juan Yang et al.
Yang-Zhou Zhang et al.
Background: Non-proliferative diabetic retinopathy (NPDR) poses a significant challenge in diabetes management due to its microvascular changes in the retina. Laser photocoagulation, a conventional therapy, aims to mitiga...
Wei Xiong,Zhao-Hui Zeng,Yuan Xu et al.
Wei Xiong et al.
Background: Gestational diabetes mellitus (GDM) is characterized by glucose intolerance that is first diagnosed during pregnancy, making it the most common complication associated with this period. Early detection and tar...
Intestinal glucagon-like peptide-1: A new player associated with impaired counterregulatory responses to hypoglycaemia in type 1 diabetic mice [0.03%]
肠道胰高血糖素样肽-1与1型糖尿病小鼠低血糖反调节障碍有关的新角色
Fang-Xin Jin,Yan Wang,Min-Ne Li et al.
Fang-Xin Jin et al.
Background: Impaired hypoglycaemic counterregulation has emerged as a critical concern for diabetic patients who may be hesitant to medically lower their blood glucose levels due to the fear of potential hypoglycaemic rea...
Does type 1 diabetes serve as a protective factor against inflammatory bowel disease: A Mendelian randomization study [0.03%]
遗传学随机对照研究：1型糖尿病是否能成为炎症性肠病的保护因素？
Ke-Ke Tong,Yun-Feng Yu,Xin-Yu Yang et al.
Ke-Ke Tong et al.
Background: The impact of type 1 diabetes (T1D) on inflammatory bowel disease (IBD) remains unclear. Aim: To analyze the causal relatio...
Association between glucose-lowering drugs and circulating insulin antibodies induced by insulin therapy in patients with type 2 diabetes [0.03%]
胰岛素治疗诱导的2型糖尿病患者的血糖降低药物与循环胰岛素抗体之间的关系
Peng Zhang,Qing Jiang,Bo Ding et al.
Peng Zhang et al.
Background: Insulin antibodies (IAs) affect blood glucose control in patients receiving insulin therapy. Aim: To investigate the relati...
Clinical efficacy of endovascular revascularization combined with vacuum-assisted closure for the treatment of diabetic foot [0.03%]
血管内血运重建联合负压封闭引流技术治疗糖尿病足的临床疗效
Feng-Rui Lei,Xiao-Fei Shen,Chuang Zhang et al.
Feng-Rui Lei et al.
Background: The diabetic foot is a common cause of disability and death, and comorbid foot infections usually lead to prolonged hospitalization, high healthcare costs, and a significant increase in amputation rates. And m...
Network pharmacology and molecular dynamics study of the effect of the Astragalus-Coptis drug pair on diabetic kidney disease [0.03%]
基于网络药理学和分子动力学的黄芩-黄芪药对干预糖尿病肾病的作用机制研究
Mo-Yan Zhang,Shu-Qin Zheng
Mo-Yan Zhang
Background: Diabetic kidney disease (DKD) is the primary cause of end-stage renal disease. The Astragalus-Coptis drug pair is frequently employed in the management of DKD. However, the precise molecular mechanism underlyi...
Sahana Shetty,Joseph M Pappachan,Cornelius James Fernandez
Sahana Shetty
Tuberculosis (TB) remains a huge global healthcare challenge even in the 21st century though the prevalence has dropped in developed countries in recent decades. Diabetes mellitus (DM) is an important risk factor for the development and per...
Global trends in publications regarding macrophages-related diabetic foot ulcers in the last two decades [0.03%]
近20年来与巨噬细胞相关糖尿病足溃疡的文献全球分布趋势分析
Jian-Ping Wen,Shuan-Ji Ou,Jia-Bao Liu et al.
Jian-Ping Wen et al.
Background: Diabetic foot ulcers (DFUs) are one of the most severe and popular complications of diabetes. The persistent non-healing of DFUs is the leading cause of ampu-tation, which causes significant mental and financi...
Update on evidence-based clinical application of sodium-glucose cotransporter inhibitors: Insight to uncommon cardiovascular disease scenarios in diabetes [0.03%]
基于证据的SGLT2抑制剂临床应用进展——糖尿病罕见心血管疾病患者的用药思考与策略
Shi-Bing Tao,Xi Lu,Zi-Wei Ye et al.
Shi-Bing Tao et al.
In this paper, we concentrate on updating the clinical research on sodium-glucose cotransporter inhibitors (SGLTis) for patients with type 2 diabetes who have heart failure with a preserved injection fraction, acute heart failure, atrial fi...